首页> 外文期刊>American Journal of Ophthalmology Case Reports >Long-term follow-up of perifoveal exudative vascular anomalous complex treated with intravitreal injections of anti-vascular endothelial growth factor and thermal laser photocoagulation
【24h】

Long-term follow-up of perifoveal exudative vascular anomalous complex treated with intravitreal injections of anti-vascular endothelial growth factor and thermal laser photocoagulation

机译:具有玻璃体内注射抗血管内皮生长因子和热激光光凝治疗的骨膜渗透性血管异常复合物的长期随访

获取原文
           

摘要

PurposeTo describe the long-term follow-up of a patient with perifoveal exudative vascular anomalous complex (PEVAC) treated initially with intravitreal injections of anti-vascular endothelial growth factor (VEGF) followed by focal thermal laser photocoagulation.ObservationsA 78 years-old man presented with large, soft drusen in both eyes. Optical coherence tomography and fluorescein angiography revealed the presence of PEVAC in the left eye. The patient was in good general health with no history of diabetes and had no signs of other retinal vascular disease. During the follow-up, the intraretinal fluid accumulation progressively increased and the best-corrected visual acuity (BCVA) dropped from 20/20 to 20/30 over a period of 33 months. As the intraretinal fluid continued to increase and BCVA further decreased to 20/50 despite two intravitreal injections of anti-VEGF, the patient underwent focal thermal laser photocoagulation with a reduction in intraretinal fluid observed 1 month later. Two months after laser, the BCVA increased to 20/25 with complete reabsorption of the intraretinal fluid. Ten months after laser, the BCVA remained stable at 20/25 with no recurrence of intraretinal fluid.Conclusions and ImportanceThis case illustrates that a PEVAC lesion may remain non-exudative for an extended period of time, but when exudation develops, anti-VEGF therapy may be ineffective requiring the use of thermal laser photocoagulation.
机译:Purposeto描述了患有患者的患者的长期随访,最初用含有抗血管内皮生长因子(VEGF)的玻璃体内注射术后,然后局灶性热激光光凝术治疗。从而提供78岁的男子两只眼睛都有大,柔软的德鲁森。光学相干断层扫描和荧光素血管造影显示Pevac在左眼中存在。患者良好的一般健康,没有糖尿病史,没有其他视网膜血管疾病的迹象。在随访期间,Intraretinal液体积累逐渐增加,最佳矫正视力(BCVA)在33个月内从20/20到20/30下降。由于抗VEGF的玻璃体内注射两次玻璃体内注射抗VEGF的玻术注射,因此,尽管抗VEGF的玻术注射进一步降低,因此,患者在1个月后观察到局灶性热激光光凝患者的患者患者。激光后两个月后,BCVA增加到20/25,内部液体的重吸收。激光后十个月,BCVA在20/25仍然保持稳定,没有内耳液的复发。结论和进一步的案例说明Pevac病变可能在延长的一段时间内保持不渗出,但是当渗出发展时,抗VEGF治疗可能无效需要使用热激光光凝。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号